Jennifer MacDiarmid

[Jennifer MacDiarmid @JenEnGene]

Vaccine for COVID mutants steals the limelight for health innovation https://t.co/BCba3uM8pi
@FinancialReview @inventium #mostinnovative2022 @DavidJoffe64 @KerryChika @NSWHealth @Mark_Butler_MP

[Jennifer MacDiarmid @JenEnGene]

Yes, masks are a must inside @normanswan @RadioNational as is EnGeneIC's vaccine that works >90% against Omicron in 50 trial recruits

[Jennifer MacDiarmid @JenEnGene]

At least Omicron has government attention.50 people in EDV-COVID trial are protected >90% against Omicron and have memory response. Why pursue endless booster mRNA vax with limited efficacy? @Mark_Butler_MP

[Jennifer MacDiarmid @JenEnGene]

@EnGeneIC Rather than a 4th booster, Aussies need EnGeneIC's no side effect COVID vaccine protecting against all variants including Omicron >90% in trials https://t.co/giSh6iDFOf
@Mark_Butler_MP @edhusicMP

[Jennifer MacDiarmid @JenEnGene]

EnGeneIC's no side effect COVID vaccine protects against all variants including Omicron >90% in trials https://t.co/giSh6iDFOf
Novel stimulation of immune response not possible with mRNA so can soon start trials in the forgotten immune compromised @drkerrynphelps@Mark_Butler_MP

[Jennifer MacDiarmid @JenEnGene]

Perhaps after 2 years of ignoring EnGeneIC's completely novel, Aussie vaccine initiative, the new government will assist in building out manufacturing capability for approach that is revolutionary across pandemics @edhusicMP @InvestmentNSW

[Jennifer MacDiarmid @JenEnGene]

EnGeneIC's no side effect COVID vaccine protects against all variants including Omicron >90% in trials https://t.co/giSh6iDFOf
Novel stimulation of immune response not possible with mRNA so can soon start trials in the forgotten immune compromised @drkerrynphelps@Mark_Butler_MP

[Jennifer MacDiarmid @JenEnGene]

Perhaps after 2 years of ignoring EnGeneIC's completely novel, Aussie vaccine initiative, the new government will assist us to build out manufacturing capability for approach that is revolutionary across pandemics @edhusicMP @InvestmentNSW

[Jennifer MacDiarmid @JenEnGene]

EnGeneIC's no side effect COVID vax protects against all variants including Omicron >90% in trials. https://t.co/giSh6iDFOf
Novel stimulation of immune response not possible with mRNA means trials soon for the forgotten immune compromised @drkerrynphelps @TGAgovau

[Jennifer MacDiarmid @JenEnGene]

@healthgovau Why push the same vaccines for immune-compromised people that have no efficacy in this population in multiple studies? @ATAGI @Mark_Butler_MP
#EnGeneIC vax safe, >90% protection against original Omicron, BA2 + specific T cells in clinical trial #COVID19vaccine @drpatrick

[Jennifer MacDiarmid @JenEnGene]

Teachers who lose jobs via Vic vaccine mandate can join Aussie EnGeneIC COVID EDV trial (not mRNA) at St Vincents in Melbourne. In 30 people so far, no side effects, >90% protection against all variants, + Omicron, vax certificate to 4/23.
@MeredithPeace @justinmullaly

[Jennifer MacDiarmid @JenEnGene]

Teachers who lose jobs via Vic vaccine mandate can join Aussie EnGeneIC COVID EDV trial (not mRNA) at St Vincents in Melbourne. In 30 people so far, no side effects, >90% protection against all variants, + Omicron, vax certificate to 4/23.
@MeredithPeace @justinmullaly

[Dr. Pat Soon-Shiong @DrPatrick]

And now after the therapy

[Jennifer MacDiarmid @JenEnGene]

@normanswan EnGeneIC's COVID EDV vax is totally safe and protecting trial recruits (20 to date) from all variants including Omicron. Why is there no Aussie interest/support?@sophiescott2@chrisbowen@anthonyalbanese

[Jennifer MacDiarmid @JenEnGene]

EnGeneIC: Potential new Covid-19 vax for mutant strains to be developed in Australia https://t.co/OJRWU4uu5l via @newscomauHQ#covidvaccines

[Sunrise @sunriseon7]

A Sydney biotech firm has developed a world-first COVID vaccine that could be more effective than the jabs currently available 💉

[Jennifer MacDiarmid @JenEnGene]

EnGeneIC's abstract at @ASCO shows EDV is safe and gives durable responses in pancreatic cancer @AvnerFoundation https://t.co/9busMtXLHh

[Jennifer MacDiarmid @JenEnGene]

We are all very proud @engeneic to have won the AFR/Boss innovation award https://t.co/mOlMLbYUlD

[Jennifer MacDiarmid @JenEnGene]

Congratulations to @johnboockvar’s team @lenoxhill @NorthwellHealth for the encouraging result in their first patient in Phase I #glioblastoma #clinicaltrial using #EnGeneIC EDV nanotechnology (https://t.co/nlDflMt4Iq).

[Jennifer MacDiarmid @JenEnGene]

Support EnGeneIC Cancer Research Foundation in Blackmores Sydney Running Festival 2017 - https://t.co/6zhOdEYObd